Meeting News
March 12, 2019
SEATTLE — Researchers presented positive findings from early-stage clinical trials of two novel HIV inhibitors at CROI. At a news conference…
Meeting News
March 12, 2019
SEATTLE — Between 2014 and 2017, the proportion of high-risk men who have sex with men who are taking pre-exposure prophylaxis, or PrEP, for…
Meeting NewsPerspective
March 12, 2019
SEATTLE — Initiating isoniazid preventive therapy for tuberculosis during pregnancy is not associated with a higher rate of poor maternal or…
Meeting News
March 11, 2019
SEATTLE — Researchers found that combining nutrition and sanitation interventions led to improved motor and cognitive development in children…
Meeting NewsPerspective
March 11, 2019
SEATTLE — Patients who initiate ART without pretherapy CD4 monitoring experience a higher risk for early mortality than those who are tested…
Meeting NewsPerspective
March 11, 2019
SEATTLE — Despite a more than 12% decrease in the overall rate of death among people living with HIV between 2011 and 2015 in the United…
Meeting NewsVideo
March 10, 2019
SEATTLE — Infectious Disease News spoke with Amita Gupta, MD, associate professor of infectious diseases at Johns Hopkins University School of…
Meeting NewsPerspective
March 9, 2019
SEATTLE — A monthly injectable two-drug regimen of cabotegravir and rilpivirine is noninferior to a daily three-drug oral regimen for the…
Meeting News
March 8, 2019
SEATTLE — A short-course drug regimen to prevent tuberculosis was found to be safe in patients with HIV on dolutegravir therapy, while not…
Meeting NewsPerspective
March 8, 2019
SEATTLE — A small pilot study of hepatitis C treatment in pregnant women found that their response to ledipasvir-sofosbuvir therapy is similar…